A phase I trial of the safety, tolerance, and pharmacokinetics of oral indinavir co-administered with lamivudine (3TC) and zidovudine (ZDV) [lamivudine/zidovudine] in HIV-1-infected pregnant women during gestation and post partum, and in their infants post maternal dosing
Phase of Trial: Phase I
Latest Information Update: 01 May 2012
At a glance
- Drugs Indinavir (Primary) ; Lamivudine/zidovudine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 21 Oct 2005 New trial record.